Leucid Bio
Operater of a cell therapy company intended to develop novel cell therapies for patients with solid tumors and no treatment options. The company specializes in the development of chimeric antigen rece...
Valuation
$25M
Market implied
Share Price
N/A
Total Raised
$30.8M
Last Round
N/A